We are pleased to announce that our Microbiome Drug Landscape Report is now available at the Microbiome Times. The report contains detailed information about the microbiome pharmaceutical industry in the last year. You will find overview recent results of earlier-stage and late-stage clinical trials, main financial rounds, the impact of the COVID on the industry and new partnerships between microbiome drug developers and big pharma.